Intravitreal corticosteroids and macular edema, a meta-analysis

Publication Date

2015

Document Type

Research

Abstract

This meta-analysis showed evidence that intravitreal corticosteroids can be used as primary treatment for macular edema of various etiologies. There is a need for more large randomized trials using various available steroids either intravitreally or topically versus macular edema to investigate its true benefit and risks for it to become a viable therapeutic option. More studies comparing its benefits and risks with those of laser and anti-vascular endothelial growth factor therapy must also be made. Intravitreal corticosteroids are a new option in posterior ocular segment disease and further long term clinical research must focus on these to determine optimal treatment parameters.

This document is currently not available here.

Share

COinS